blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1864675

EP1864675 - Orally administered peptides to ameliorate atherosclerosis [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.03.2012
Database last updated on 06.07.2024
Most recent event   Tooltip27.09.2013Lapse of the patent in a contracting state
New state(s): TR		published on 30.10.2013  [2013/44]
Applicant(s)For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
For all designated states
The UAB Research Foundation
701 South 20th Street Suite 1120G
Birmingham, AL 35291-0111 / US
[N/P]
Former [2010/02]For all designated states
The Regents of the University of California
12th Floor 1111 Franklin Street
Oakland, CA 94607-5200 / US
For all designated states
The UAB Research Foundation
701 South 20th Street Suite 1120G
Birmingham, AL 35291-0111 / US
Former [2007/50]For all designated states
The Regents of the University of California
12th Floor 1111 Franklin Street
Oakland, CA 94607-5200 / US
Inventor(s)01 / Fogelman, Alan M.
481 Hillgreen Drive
Beverly HIlls, CA 90212-4107 / US
02 / Navab, Mohammad
1135 North Bundy Drive
Los Angeles, CA 90049 / US
03 / Anantharamaiah, Gattadahalli M.
3798 Carlsbrooke Drive
Birmingham, AL 35226 / US
 [2007/50]
Representative(s)Ward, David Ian
Marks & Clerk LLP
Alpha Tower
Suffolk Street
Queensway
Birmingham B1 1TT / GB
[N/P]
Former [2007/50]Ward, David Ian
Marks & Clerk Alpha Tower Suffolk Street Queensway
Birmingham B1 1TT / GB
Application number, filing date07007775.523.08.2001
[2007/50]
Priority number, dateUS2000064545424.08.2000         Original published format: US 645454
[2007/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1864675
Date:12.12.2007
Language:EN
[2007/50]
Type: B1 Patent specification 
No.:EP1864675
Date:27.04.2011
Language:EN
[2011/17]
Search report(s)(Supplementary) European search report - dispatched on:EP07.11.2007
ClassificationIPC:A61K38/03, A61K38/08, A61K38/10, A61K38/17, C07K14/775
[2007/50]
CPC:
C07K14/775 (EP,US); A61P11/00 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P19/02 (EP); A61P19/10 (EP);
A61P21/00 (EP); A61P25/28 (EP); A61P29/00 (EP);
A61P3/04 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P31/04 (EP); A61P31/06 (EP); A61P31/08 (EP);
A61P31/10 (EP); A61P31/12 (EP); A61P31/18 (EP);
A61P33/00 (EP); A61P37/02 (EP); A61P37/04 (EP);
A61P37/06 (EP); A61P39/06 (EP); A61P43/00 (EP);
A61P7/00 (EP); A61P9/00 (EP); A61P9/08 (EP);
A61P9/10 (EP); A61P9/12 (EP); A61P9/14 (EP);
A61K38/00 (EP,US); Y02P20/55 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2007/50]
TitleGerman:Oral verabreichte Peptide zur Linderung von Atherosklerose[2007/50]
English:Orally administered peptides to ameliorate atherosclerosis[2007/50]
French:Peptides administrés oralement pour améliorer l'athérosclérose[2007/50]
Examination procedure02.05.2007Examination requested  [2007/50]
29.04.2008Despatch of a communication from the examining division (Time limit: M06)
03.11.2008Reply to a communication from the examining division
15.07.2009Despatch of a communication from the examining division (Time limit: M04)
25.11.2009Reply to a communication from the examining division
01.02.2011Communication of intention to grant the patent
11.03.2011Fee for grant paid
11.03.2011Fee for publishing/printing paid
Parent application(s)   TooltipEP01966198.2  / EP1318828
Opposition(s)30.01.2012No opposition filed within time limit [2012/14]
Fees paidRenewal fee
02.05.2007Renewal fee patent year 03
02.05.2007Renewal fee patent year 04
02.05.2007Renewal fee patent year 05
02.05.2007Renewal fee patent year 06
29.08.2007Renewal fee patent year 07
25.08.2008Renewal fee patent year 08
25.08.2009Renewal fee patent year 09
25.08.2010Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.04.2011
BE27.04.2011
CY27.04.2011
DK27.04.2011
FI27.04.2011
IT27.04.2011
NL27.04.2011
SE27.04.2011
TR27.04.2011
GR28.07.2011
ES07.08.2011
IE23.08.2011
LU23.08.2011
PT29.08.2011
MC31.08.2011
[2013/44]
Former [2013/25]AT27.04.2011
BE27.04.2011
CY27.04.2011
DK27.04.2011
FI27.04.2011
IT27.04.2011
NL27.04.2011
SE27.04.2011
GR28.07.2011
ES07.08.2011
IE23.08.2011
LU23.08.2011
PT29.08.2011
MC31.08.2011
Former [2012/35]AT27.04.2011
BE27.04.2011
CY27.04.2011
DK27.04.2011
FI27.04.2011
IT27.04.2011
NL27.04.2011
SE27.04.2011
GR28.07.2011
ES07.08.2011
IE23.08.2011
PT29.08.2011
MC31.08.2011
Former [2012/24]AT27.04.2011
BE27.04.2011
CY27.04.2011
DK27.04.2011
FI27.04.2011
IT27.04.2011
NL27.04.2011
SE27.04.2011
GR28.07.2011
ES07.08.2011
PT29.08.2011
MC31.08.2011
Former [2012/18]AT27.04.2011
BE27.04.2011
CY27.04.2011
DK27.04.2011
FI27.04.2011
NL27.04.2011
SE27.04.2011
GR28.07.2011
ES07.08.2011
PT29.08.2011
MC31.08.2011
Former [2012/11]AT27.04.2011
BE27.04.2011
CY27.04.2011
DK27.04.2011
FI27.04.2011
NL27.04.2011
SE27.04.2011
GR28.07.2011
ES07.08.2011
PT29.08.2011
Former [2012/01]AT27.04.2011
BE27.04.2011
CY27.04.2011
FI27.04.2011
NL27.04.2011
SE27.04.2011
GR28.07.2011
ES07.08.2011
PT29.08.2011
Former [2011/49]CY27.04.2011
FI27.04.2011
SE27.04.2011
GR28.07.2011
ES07.08.2011
PT29.08.2011
Former [2011/47]PT29.08.2011
Documents cited:Search[A]US5344822  (LEVINE DANIEL M [US], et al) [A] 1-15 * column 2, line 25 - line 30; figure 4 * * example 1 *;
 [X]WO9916408  (DASSEUX JEAN LOUIS [US], et al) [X] 1-15 * page 117; example 6; sequence 243 *;
 [A]WO9916409  (DASSEUX JEAN LOUIS [US], et al) [A] 1-15* tables VI,VIII; sequence 243 *
by applicantUS4643988
    - GARBER ET AL., ARTERIOSCLEROSIS AND THROMBOSIS, (1992), vol. 12, pages 886 - 894
    - LEVINE ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 12040 - 12044
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.